Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sofamor Danek tissue resector

This article was originally published in The Gray Sheet

Executive Summary

Designed to remove bulging or herniated discs "in a minimally invasive manner" will be launched this month, President and CEO Ron Pickard told investors at the recent Hambrecht & Quist life sciences conference in San Francisco. In addition, the firm's disc spacer is scheduled to enter European clinicals this year, with an investigational device exemption expected to be filed with FDA later in 1994. The firm also hopes to start European clinicals for its prosthetic disc late this year, with an IDE submission anticipated in 1995
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT001789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel